MINNEAPOLIS--(BUSINESS WIRE)--HistoSonics, the developer and manufacturer of the Edison® Histotripsy System, announced today the first patients were enrolled in their novel prospective master protocol ...
Lung Cancer Master Protocol (Lung-MAP), a public-private partnership, established infrastructure for conducting a biomarker-driven master protocol in molecularly targeted therapies. We compared ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback